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Copyright © 200? JCBN 2012 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. The stomach is a sensitive digestive organ that is susceptible and
exposed to exogenous pathogens from the diet. In response to
such pathogens, the stomach induces oxidative stress, which
might be related to the development of gastric organic disorders
such as gastritis, gastric ulcers, and gastric cancer, as well as func 
tional disorders such as functional dyspepsia. In particular, the
bacterium Helicobacter pylori plays a major role in eliciting and
confronting oxidative stress in the stomach. The present paper
summarizes the pathogenesis of oxidative stress in the stomach
during the development of various stomach diseases.
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Oxidative Stress in the Process of Gastric Mucosal Injury
Physiological responses to stressors include increased activity
of the hypothalamic-pituitary-adrenal axis as well as changes in
gastrointestinal tissue. According to Selye’s formulation of the
general adaptation syndrome, an increase in adrenocortical
activity is related to an increase in the incidence of gastric
ulceration. The main candidate for the cause of stress ulcers is
oxidative stress. There is some evidence that psychological stress,
in addition to physical stress such as surgical intervention and
microbial infection including Helicobacter pylori (H. pylori),(1)
leads to oxidative stress in the stomach. Oxidative stress, which is
a state of elevated levels of reactive oxygen species (ROS), causes
a variety of conditions that stimulate either additional ROS pro-
duction or a decline in antioxidant defenses. Oxidative stress is
not only involved in the pathogenesis of gastric inflammation,
ulcerogenesis, and carcinogenesis in H. pylori infection, but
also in that of lifestyle-related diseases including atherosclerosis,
hypertension, diabetes mellitus, ischemic heart diseases, and
malignancies.(2) Several phenotypes of gastrointestinal diseases,
such as peptic ulcer disease and gastroparesis, are known to be
related to antioxidant property dysfunction.
Ethanol. The effects of ethanol on gastric mucosa are compli-
cated and multifaceted. They may be associated with a disturbance
in the balance between gastric mucosal protective and aggressive
factors. Gastric mucosa is exposed to gastric acid, pepsin, and
stimulants among others, while gastroprotective factors maintain
the integrity of the gastric mucous layer, microcirculatory system,
HCO3−, prostaglandins (PGs), epidermal growth factor synthesis,
and epithelial cell restitution. Ethanol injures the vascular endo-
thelial cells of the gastric mucosa and induces microcirculatory
disturbance and hypoxia, linking to the overproduction of oxygen
radicals.
Pan et al.(3) report the role of mitochondrial energy charge in
the pathogenesis of ethanol-induced gastric mucosal injury. The
gastric mucosal lesion index is correlated with the thiobarbituric
acid (TBA)-reactive substance (TBARS) content in gastric
mucosa. As the concentration of ethanol increases and the
exposure time to ethanol is extended, the TBARS content in
gastric mucosa and the extent of gastric mucosal damage increase.
The ultrastructural pathological changes in mitochondria are
positively related to ethanol concentration and exposure time. The
expressions of mitochondrial DNA ATPase subunits 6 and
8 mRNA decline with increasing TBARS content in gastric
mucosa produced as a result of ethanol gavage. As mentioned
above, ethanol-induced gastric mucosal injury is related to oxida-
tive stress, which disturbs the energy metabolism of mitochondria
and plays a critical role in the pathogenesis of ethanol-induced
gastric mucosal injury.
Ischemia/reperfusion injury. Ischemia/reperfusion damages
the gastric mucosa by inducing oxidative stress. Specifically, ROS
such as superoxide (O2−) and hydrogen peroxide (H2O2) induce
inflammatory responses and tissue damage by fragmenting cellular
DNA. In the gut, ROS can also be generated by non-steroidal anti-
inflammatory drugs (NSAIDs), cold stress, ethanol, and H. pylori
infection. NADPH oxidase found in phagocytic cells, vascular
smooth muscle cells, endothelial cells, fibroblasts, and adipocytes
convert oxygen into superoxide anions. Nakagiri et al.(4) recently
reported that NADPH oxidase activity is elevated in ischemia and
ischemia/reperfusion and is involved in the resultant gastric
mucosal damage. This increased NADPH oxidase activity may
also upregulate cyclooxygenase-2.
Peskar et al.(5) report that during ischemia/reperfusion, inhibitors
of the cyclooxygenase and lipoxygenase pathways increase gastric
mucosal damage in a dose-dependent manner. The synergism
observed as a result of the combination of cyclooxygenase and
lipoxygenase inhibitors suggests that both pathways are important
in gastric mucosal defense during ischemia/reperfusion. PGE2
theoretically antagonizes the effects of cyclooxygenase and
lipoxygenase inhibitors. Similarly, lipoxin A4, a lipoxygenase-
derived product of arachidonate metabolism, also antagonizes the
effects of cyclooxygenase and lipoxygenase inhibitors; moreover,
it could replace PGE2 for the prevention of gastric mucosal
damage caused by cyclooxygenase inhibitors during ischemia/
reperfusion.
Portal hypertensive gastropathy. Portal hypertensive
gastropathy (PHG) is a common complication of liver cirrhosis
and is associated with impaired gastric mucosal healing. PHG may
be related to increased ROS and lipid peroxide (LPO) production.
Kinjo et al.(4) report increased levels of LPO and nitrotyrosine, an
indicator of nitration of tyrosine residues due to peroxynitrite, in
the gastric mucosa of portal hypertensive rats; in addition, they
report impaired ERK1/2 phosphorylation related to increased
nitration by peroxynitrite. The gastroprotective, anti-inflammatory
agent rebamipide prevents free radical production by scavengingdoi: 10.3164/jcbn.11 115SR
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hydroxyl radicals.(5,6) Rebamipide decreases LPO and nitrotyrosine
levels, normalizes ERK1/2 phosphorylation, and improves the
ulcer index; this suggests that defects in the mitogen-activated
protein kinase (MAPK) pathway are involved in the increased
susceptibility to gastric mucosal injury observed in portal hyper-
tensive gastropathy, indicating a potential role of rebamipide for
treatment.
NSAIDs and aspirin. In addition to inhibiting cyclooxygenase
and decreasing prostaglandin production, NSAIDs induce mucosal
damage via ROS produced by recruited leukocytes. ROS-mediated
mitochondrial damage as well as lipid, protein, and DNA oxida-
tion lead to apoptosis and mucosal injury. Proton pump inhibitor
(PPI) therapy is thought to primarily protect gastric mucosa by
inhibiting gastric acid secretion. Nevertheless, Maity et al.(7)
recently demonstrated that a PPI, lansoprazole, also inhibits
NSAID-induced gastropathy by inhibiting mitochondrial and
Fas-mediated apoptosis pathways. Lansoprazole’s anti-apoptotic
activity appears to be mediated by preventing NSAID-induced
reductions in anti-apoptotic genes (e.g., Bcl and Bcl-2) while
inhibiting increases in Fas and Fas ligand as well as pro-apoptotic
genes (e.g., Bax and Bak).
On the other hand, aspirin increases the permeability of cultured
gastric epithelial cell monolayers. The disruption in barrier
integrity is mediated by p38 MAPK and involves the downregula-
tion of claudin-7, a protein component of tight junctions.(8) This
differs from the effects of other NSAIDs (i.e., non-aspirin
NSAIDs), which increase epithelial permeability coupled to
cyclooxygenase-1 inhibition; this increase can be restored by
PGE2 administration.
Heat shock proteins. Heat shock proteins, especially HSP70,
provide cellular protection against stressor-induced tissue damage
by refolding or degrading denatured proteins produced as a result
of these stressors. Otaka et al.(9) recently used affinity chromato-
graphy to identify cytoskeletal myosin and actin as the first
molecules bound by HSP70 after gastric mucosal injury in rats.
Transcriptional upregulation of HSPs occurs via the binding of
the transcription factor, heat shock factor 1 (HSF1), to heat shock
element, which is located upstream of the HSP genes. In HSF1
null and HSP70-expressing transgenic mice, HSPs protect against
irritant (e.g., ethanol or NSAIDs)-induced gastric lesions; more-
over, geranylgeranylacetone (GGA), a gastroprotective agent,
induces HSPs. Furthermore, HSP70 protects the gastric mucosa
by inhibiting apoptosis, proinflammatory cytokines, and cell
adhesion molecules involved in leukocyte infiltration. After
induction by GGA, HSPs exhibit protective effects in mouse
models of inflammatory bowel disease as well as in NSAID-
induced lesions of the small intestine. Therefore, HSP inducers
such as GGA may have therapeutic benefits in numerous diseases.
Enlarged Fold Gastritis and Oxidative Stress
H. pylori eradication therapy increases Runt domain transcrip-
tion factor 3 (RUNX3) expression in glandular epithelial cells in
enlarged-fold gastritis. Recently, we reported that RUNX3 is
expressed in gastric epithelial cells and that H. pylori eradication
significantly increases RUNX3 expression in the glandular
epithelium of the corpus; however, no changes were observed
in the antrum.(10) The mucosal chemiluminescence value, a marker
of oxidative stress, is 4-fold higher in the corpus than in the
antrum. H. pylori eradication significantly decreases the mucosal
chemiluminescence values in both portions of the stomach to
nearly undetectable levels. We conclude that the glandular
epithelium is exposed to high levels of carcinogenic oxidative
stress and expresses low levels of the tumor-suppressing mole-
cule, RUNX3; however, RUNX3 expression was restored after
eradication, suggesting a high risk of carcinogenesis associated
with H. pylori-induced enlarged-fold gastritis of the corpus.(10)
Oxidative Stress during H. pylori Infection
Antioxidant ability of H. pylori to establish chronic infec 
tion. H. pylori infection induces a strong inflammatory host
response, leading to the generation of a number of ROS and
reactive nitrogen species (RNS), which are mediated by neutro-
phils and macrophages.(11) The generation of ROS and/or RNS is
an important host immune response against persistent pathogens.
Therefore, H. pylori must combat oxidative stress generated by
the host immune response using an antioxidant protein in order to
establish long-term colonization.(12,13) The mechanisms for ROS
detoxification are of particular interest in understanding the H.
pylori-associated pathogenesis. It is well known that H. pylori has
a variety of enzymes acting as antioxidant systems to combat the
toxic effects of ROS including catalase (KatA), iron-cofactored
superoxide dismutase (SodB), and alkyl hydroperoxide reductase
(AhpC).(13,14)
Superoxide dismutase (SOD) catalyzes the conversion of super-
oxide anions to hydrogen peroxide, which is degraded to oxygen
and water by catalase.(13,15) SOD is a metalloenzyme; 3 structurally
different forms have been identified depending on the metal
cofactor. In general, organisms encode different sets of SOD
enzymes. For example, Escherichia coli has 3 SODs: Fe-SOD
(SodB) and Mn-SOD (SodA) in the cytoplasm and Cu/Zn-SOD
in the periplasm.(16) On the other hand, H. pylori produces only a
single SodB encoded by the sodB gene.(17,18) It was recently
reported that sodB deletion in H. pylori causes the bacterium to
lose its capacity for gastric mucosal colonization in mice.(19) This
indicates that SodB is an important determinant of the host
colonization capability of H. pylori. The regulation of sodB
mRNA expression is also important for ROS detoxification. The
mRNA expression of sodB in H. pylori is directly regulated by
ferric uptake regulator (Fur) protein.(20) Fur functions as a global
transcriptional regulator in H. pylori.(21–24) It is reported that Fur
binds to ferrous iron (Fe2+) and that the genes for iron uptake are
suppressed by the iron-binding form of Fur.(25,26) On the other
hand, sodB expression is suppressed by the iron-free form of Fur
(apo-Fur).(20) Apo-Fur binds to a specific consensus sequence
called Fur-Box located on the sodB promoter, blocking the
binding of RNA polymerase.(20,27,28) It was recently reported that
nucleic-acid mutations in Fur-Box and/or amino-acid mutations in
Fur decrease the affinity of apo-Fur for Fur-Box in H. pylori,
halting the suppression of sodB mRNA expression.(29–31) In
particular, stopping the suppression of sodB mRNA expression in
H. pylori by amino-acid mutations in Fur (i.e., C78Y and P114S)
determines the development of metronidazole (Mtz) resistance.(31)
This is because, when Mtz enters cells, its antimicrobial toxicity is
dependent on the reduction of its nitro group to nitro anion radicals
and the generation of superoxide.(32,33)
The SodB of H. pylori shares 53% sequence identity with the
corresponding protein from E. coli. Interestingly, H. pylori SodB
is significantly different from other Fe-SODs; its most distin-
guishing characteristic is its extended C-terminal tail,(34) although
the role of this tail remains unclear. The structure of SodB has
been clarified; it is now known to exist as a dimer composed of 2
identical subunits.(34) Furthermore, it is identified as having 4
ferrous ion (Fe2+)-coordinating residues (i.e., an iron-binding
domain; His 26, His 73, His 160, and Asp 156) (Fig. 1). In fact,
SodB needs to recruit ferrous ion (Fe2+) to express its activity.(15,34)
It is expected that SodB activity might be suppressed by preventing
the uptake of iron ion (Fe2+ and/or Fe3+).
Generation of oxidative stress as a virulence factor in H.
pylori infected hosts. ROS released from activated neutro-
phils are also potential virulence factors involved in H. pylori-
infected host cells. In H. pylori-infected host cells, hypochlorous
anions (OCl−) are generated from H2O2 in the presence of Cl−. The
hypochlorous anions subsequently react with ammonia (NH3),
which is derived from urea by urease produced by H. pylori, J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 37
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ultimately yielding monochloramine (NH2Cl). NH2Cl induces
mucosal cytotoxicity due to its lipophilic properties and freely
penetrates biological membranes to oxidize intracellular compo-
nents.(35–37)
In addition, it is well known that H. pylori produces a γ-
glutamyltranspeptidase (EC 2.3.2.2; GGT) in the periplasm.(38) H.
pylori GGT catalyzes the transpeptidation and hydrolysis of the
γ-glutamyl groups of glutamine and glutathione. Interestingly,
these findings indicate that H. pylori GGT performs 2 functions.
First, GGT functions in the physiological functioning of H. pylori.
H. pylori is unable to take up extracellular glutamine and
glutathione directly; GGT hydrolyzes these substances to gluta-
mate. The glutamate is then transported into H. pylori cells via a
Na+-dependent reaction and is mainly incorporated into the TCA
cycle.(39) Second, GGT acts as a virulence factor by disrupting the
antioxidant ability of host cells. Although glutathione has anti-
oxidant potential in host cells, H. pylori GGT reduces extracellular
glutathione levels. In fact, H. pylori GGT reduces the ROS
resistance of the host cells and induces apoptosis or necrosis.(38,40)
Excess ROS are produced in H. pylori-colonized human
stomachs; this induces oxidative stress to both the gastric mucosa
and H. pylori. Because H. pylori has a deft capability of detoxi-
fying ROS using a variety of enzymes to establish long-term
colonization,(12,13) excess ROS leads solely to host cell damage.
Oxidative Stress in the Progression of Gastric Motility
Disorders
Gastric motility disorders can occur in many clinical settings
with a wide variety in the severity of symptoms with or without
gastric mucosal injuries. Gastric motility disorders are attributable
to either damage within the smooth muscle itself or dysfunctions
within the neuromuscular components including the enteric nerves
and interstitial cells of Cajal (ICC), which regulate smooth muscle
function. How oxidative stress is involved in these dysfunctions is
discussed in the following situations.
Gastrointestinal Complications in Sepsis
Oxygen radicals are implicated as relevant mediators in sepsis
and septic shock in animals including humans.(41,42) Sepsis is a
systemic response caused by bacterial endotoxins such as lipo-
polysaccharide, which induce the release of ROS and the genera-
tion of numerous pro-inflammatory factors and nitric oxide. During
sepsis, the most frequent complications within the gastrointestinal
tract are gastrointestinal motility disturbances and mucosal barrier
dysfunction. Experimental administration of LPS delays gastric
emptying and upregulates inducible nitric oxide synthase in order
to downregulate neuronal nitric oxide synthase (nNOS) and
synthesize PGs.(43) It is also reported that SOD reverses the
endotoxin-induced delay in gastric emptying and diminishes the
presence of nitrotyrosine, 4-hydroxy-2-nonenal in gastric mucosa,
and inducible nitric oxide synthase-positive residential macro-
phages in the external musculature; these suggest the involvement
of oxidative and nitrosative stresses in the pathogenesis of
lipopolysaccharide-induced gastrointestinal dysmotility.(44)
Gastrointestinal Complications in Ischemia/Reperfusion
Injury
The gastrointestinal tract is one of the most susceptible organ
systems to ischemia. Previous investigations demonstrate that
ischemia/reperfusion is a major contributor to gastric mucosal
injury caused by stresses such as burn stress or hemorrhagic
shock, NSAIDs, and H. pylori infection. In addition to mucosal
injuries, delayed gastric emptying is also reported after gastric
ischemia/reperfusion associated with disruption of the ICC network
and nNOS-positive neurons.(45) ICC play critical roles in gastro-
intestinal motility in that they are the source of the electrical slow
waves underlying the phasic contractions of the gastric muscula-
ture and mediate excitatory and inhibitory inputs to the muscula-
ture from the enteric motor neurons. Neuronal NOS generates
neuronally derived NO, which is the major inhibitory neuro-
transmitter in the gastrointestinal tract. ICC and nNOS-positive
neurons are both important factors for gastric emptying. Oxidative
stress produced by the xanthine–xanthine oxidase system after
ischemia/reperfusion may play a major role in these events,
although the precise mechanism is unclear.
Diabetes Mellitus
Oxidative stress is a strong pathogenic co-factor involved in the
development of complications of diabetes. Increased glucose
levels in diabetes react non-enzymatically with proteins and
become advanced glycation end products (AGEs); AGEs activate
endothelial NADPH oxidase and increase endothelial ROS,(46)
which occurs in animal models of diabetes(47) and diabetes
patients.(48) Gastric neuromuscular dysfunction occurs in up to 30–
50% of patients after 10 years of type 1 or 2 diabetes associated
with histological changes including the loss of nNOS and ICC in
both humans and animal models. It is reported that increased
oxidative stress is attributable to the loss of upregulation of heme
oxygenase-1; this results in the loss of ICC, decreased nNOS
expression, and delayed gastric emptying in non-obese diabetic
mice. These changes can be reversed by heme oxygenase-1
induction, demonstrating an important role of oxidative stress in
the development of diabetic gastroparesis.(49)
Aging and Oxidative Stress
Gastrointestinal function declines with aging, including delayed
gastric emptying, decreased peristalsis, and slowed colonic transit;
these impair quality of life and increase morbidity and mortality.
Notable changes in gut neuromuscular function that accompany
advanced age are reported in human and animal models.(50,51)
Cowen et al.(52) report a 50% reduction in ileal myenteric neurons
in 24-month-old Sprague-Dawley rats fed ad libitum; this was
prevented by caloric restriction, which reduces oxidative stress.(53)
In the study using progeric mice deficient in the anti-aging
peptide Klotho, progeric mice exhibited a gastric phenotype
resembling that of human aging involving profound ICC loss with
reduced slow wave amplitude and nitrergic inhibitory junction
potentials. Klotho protects ICC by preserving their precursors,
limiting oxidative stress, and maintaining nutritional status and
normal levels of trophic factors important for ICC differentia-
tion.(54) Increased oxidative stress in combination with a decrease
Fig. 1. Homology modeling of Helicobacter pylori SodB. Four amino
acids (His 26, His 73, His 160, and Asp 156) of SodB are ferrous ion (Fe2+) 
coordinating residues (i.e., an iron binding domain).doi: 10.3164/jcbn.11 115SR
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in circulating and tissue factors that regulate ICC differentiation
and survival contribute to the profound depletion of mature ICC
and impair gastric function.
Conclusion
In conclusion, oxidative stress is one of the major contributors
to the development of stomach diseases. Recent therapeutic
options such as gastroprotective agents including antioxidant
properties (e.g., rebamipide) can modulate the level of oxidative
stress to enhance anti-inflammatory or antioxidant capacity. The
stomach is an organ in direct contact with external pathogens; by
presenting a strong acid environment, it has a special biological
defense mechanism that eliminates such pathogens. However,
H. pylori manages to live in the stomach by breaking through this
defensive line. In response to the colonization of this bacterium,
gastric mucosa can be exposed to severe oxidative stress with
considerable levels of inflammatory cell accumulation, which
might be related to the development of gastric mucosal as well
as neuromuscular disorders.
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